An inspection of the site was conducted from 05 to 08 May 2026. Two critical deficiencies and three major deficiencies from GMP were raised. The critical deficiencies concerned the failure to implement a comprehensively designed and correctly implemented PQS incorporating GMP and QRM, evidenced by the failure to ensure that robust and reliable batch control procedures were in place, as well as the failure of the Qualified Persons to ensure that each individual batch had been manufactured and checked in compliance the requirements of GMP. Action taken/proposed by the NCA: Action taken/proposed: suspension in full Withdrawal of current valid GMP certificates: UK MIA(IMP) 322 INSP IMP 322/14798-0031[I]
Inspection Record
NORGINE LIMITED — MHRA GMP NCR Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
1Validation and qualification
About this record
Extracted automatically from the document UK MHRA published on 2026-08-03. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
